Inovio Pharmaceuticals, Inc. (INO) Reports In-Line Q3 Loss of 5c/Share

November 7, 2012 5:00 PM

Inovio Pharmaceuticals, Inc. (NYSE: INO) reported Q3 EPS of ($0.05) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found